46 related articles for article (PubMed ID: 19059443)
1. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.
Sleeman K; Stein DA; Tamin A; Reddish M; Iversen PL; Rota PA
Virus Res; 2009 Mar; 140(1-2):49-56. PubMed ID: 19059443
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.
Ge Q; Pastey M; Kobasa D; Puthavathana P; Lupfer C; Bestwick RK; Iversen PL; Chen J; Stein DA
Antimicrob Agents Chemother; 2006 Nov; 50(11):3724-33. PubMed ID: 16966399
[TBL] [Abstract][Full Text] [Related]
3. Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer.
Zhang J; Stein DA; Timoney PJ; Balasuriya UB
Virus Res; 2010 Jun; 150(1-2):138-42. PubMed ID: 20206215
[TBL] [Abstract][Full Text] [Related]
4. An alternative strategy to increasing influenza virus replication for vaccine production in chicken embryo fibroblast (DF-1) cells by inhibiting interferon alpha and beta using peptide-conjugated phosphorodiamidate morpholino oligomers.
Prescott MA; Moulton H; Pastey MK
J Med Microbiol; 2024 Feb; 73(2):. PubMed ID: 38353513
[No Abstract] [Full Text] [Related]
5. Target analysis of the experimental measles therapeutic AS-136A.
Yoon JJ; Krumm SA; Ndungu JM; Hoffman V; Bankamp B; Rota PA; Sun A; Snyder JP; Plemper RK
Antimicrob Agents Chemother; 2009 Sep; 53(9):3860-70. PubMed ID: 19528268
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice.
Lai SH; Stein DA; Guerrero-Plata A; Liao SL; Ivanciuc T; Hong C; Iversen PL; Casola A; Garofalo RP
Mol Ther; 2008 Jun; 16(6):1120-8. PubMed ID: 18443602
[TBL] [Abstract][Full Text] [Related]
7. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers for In Situ Live-Cell Molecular Imaging of Dengue Virus Replication.
Victorio CBL; Novera W; Tham JY; Watanabe S; Vasudevan SG; Chacko AM
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291644
[TBL] [Abstract][Full Text] [Related]
8. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
[TBL] [Abstract][Full Text] [Related]
9. Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.
Reynard O; Gonzalez C; Dumont C; Iampietro M; Ferren M; Le Guellec S; Laurie L; Mathieu C; Carpentier G; Roseau G; Bovier FT; Zhu Y; Le Pennec D; Montharu J; Addetia A; Greninger AL; Alabi CA; Brisebard E; Moscona A; Vecellio L; Porotto M; Horvat B
Nat Commun; 2022 Oct; 13(1):6439. PubMed ID: 36307480
[TBL] [Abstract][Full Text] [Related]
10. Identification of Host Factors of Paramyxoviruses by siRNA Genome-Wide Screens.
Yan B; Sigmundsson K; Ooi YS; Anderson DE
Methods Mol Biol; 2024; 2808():105-120. PubMed ID: 38743365
[TBL] [Abstract][Full Text] [Related]
11. Helical peptides with disordered regions for measles viruses provide new generalized insights into fusion inhibitors.
Hirata K; Takahara A; Suzuki S; Murakami S; Kawaji K; Nishiyama A; Sasano M; Shoji-Ueno M; Usui E; Murayama K; Hayashi H; Oishi S; Kodama EN
iScience; 2024 Feb; 27(2):108961. PubMed ID: 38333694
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives.
Todorovski T; Kalafatovic D; Andreu D
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839679
[TBL] [Abstract][Full Text] [Related]
13. Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.
Khairkhah N; Namvar A; Bolhassani A
Mol Biotechnol; 2023 Sep; 65(9):1387-1402. PubMed ID: 36719639
[TBL] [Abstract][Full Text] [Related]
14. Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles.
Bakowski K; Vogel S
RNA Biol; 2022 Jan; 19(1):1256-1275. PubMed ID: 36411594
[TBL] [Abstract][Full Text] [Related]
15. Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds.
Schmitz KS; Lange MV; Gommers L; Handrejk K; Porter DP; Alabi CA; Moscona A; Porotto M; de Vries RD; de Swart RL
Viruses; 2022 May; 14(6):. PubMed ID: 35746658
[TBL] [Abstract][Full Text] [Related]
16. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
17. Cell-Penetrating Peptides for Antiviral Drug Development.
Delcroix M; Riley LW
Pharmaceuticals (Basel); 2010 Mar; 3(3):448-470. PubMed ID: 27713263
[TBL] [Abstract][Full Text] [Related]
18. Synergizing vaccinations with therapeutics for measles eradication.
Plemper RK; Hammond AL
Expert Opin Drug Discov; 2014 Feb; 9(2):201-14. PubMed ID: 24303998
[TBL] [Abstract][Full Text] [Related]
19. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
[TBL] [Abstract][Full Text] [Related]
20. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
